Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.0540
-0.0040 (-6.90%)
Sep 11, 2026, 12:07 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 28.4 million as of September 10, 2026. Its market cap has decreased by -64.44% in one year.
Market Cap
28.40M
Enterprise Value
32.07M
Revenue
2.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 28.40M, an increase of 284.94%. That is a compound annual growth rate of 5.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 28.40M | -75.46% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 39.04M |
| Nexsen | 36.04M |
| Proteomics International Laboratories | 23.98M |
| EZZ Life Science Holdings | 23.77M |
| NeuroScientific Biopharmaceuticals | 23.38M |
| Noxopharm | 22.43M |
| Argenica Therapeutics | 21.84M |
| Patrys | 21.33M |